Morgan Stanley upgrades this small cap semiconductor stock on auto cycle recovery

Morgan Stanley has upgraded Melexis (EBR:MLXS) to Overweight and raised its price target to €80 from €60, forecasting FY26 EPS of €3.95. The upgrade is predicated on increasing confidence in a cyclical recovery within the automotive semiconductor market, evidenced by improving book-to-bill ratios and order trends, which is expected to significantly benefit Melexis given its over 85% auto revenue exposure and strong China market position. Despite recent stock gains, the firm views Melexis' current valuation as favorable relative to historical levels and peers, anticipating further upside from structural tailwinds like rising semiconductor content in vehicles and future robotics opportunities.

Analysis

Morgan Stanley has upgraded Melexis (EBR:MLXS) to Overweight, raising its price target to €80 from €60, signaling strong conviction in a cyclical recovery for the automotive semiconductor market. The new price target is based on a 20x multiple applied to fiscal 2026 estimated earnings of €3.95 per share. Analysts cite improving industry fundamentals, including rising book-to-bill ratios and order trends, as evidence that the sector is in the "early innings" of a rebound after a five-quarter downturn. Melexis is seen as a prime beneficiary due to its significant leverage to the auto industry, which constitutes over 85% of its revenue. The company's strategic position in China, which accounted for 28% of Q1 sales and saw more design wins than Europe in Q4 2024 for the first time, is a key growth driver, with its plan for local manufacturing in 2026 expected to mitigate displacement risk. Despite a recent stock appreciation of approximately 48% from April lows, the analysis suggests further upside, as the shares remain 40% below their March 2023 peak and the 20x target multiple is below the company's historical median of 22x and in line with peers like STMicroelectronics and Infineon. Long-term structural tailwinds, such as increasing semiconductor content in vehicles and a nascent opportunity in robotics, further support the positive outlook, although material revenue from robotics is not anticipated before 2028.

Key Decisions for Investors

• Investors with a bullish view on the automotive sector should consider Melexis as a focused investment to gain exposure to the early stages of a semiconductor cyclical recovery.
• Despite the stock's significant recent rally, the valuation remains below its historical median, suggesting a potentially favorable entry point for those anticipating continued momentum in auto-chip demand.
• Monitor key performance indicators such as book-to-bill ratios and the company's progress on its China-based manufacturing plans, as these are critical to validating the investment thesis.
• For those with a long-term horizon, the company's exposure to the robotics sector via its tactile sensor technology represents a potential source of future growth, supplementing the core automotive business.